Case Western Reserve researchers use AI with routine CT scans to predict how well lung cancer patients will respond to expensive treatment based off changes in texture patterns inside and outside the tumor.
Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence (AI) to predict whether chemotherapy will be successful, can now determine which lung-cancer patients will benefit from expensive immunotherapy.
And, once again, they’re doing it by teaching a computer to find previously unseen changes in patterns in CT scans taken when the lung cancer is first diagnosed compared to scans taken after the first 2-3 cycles of immunotherapy treatment. And, as with previous work, those changes have been discovered both inside—and outside—the tumor, a signature of the lab’s recent research.
“This is no flash in the pan—this research really seems to be reflecting something about the very biology of the disease, about which is the more aggressive phenotype, and that’s information oncologists do not currently have,” said Anant Madabhushi, whose Center for Computational Imaging and Personalized Diagnostics (CCIPD) has become a global leader in the detection, diagnosis and characterization of various cancers and other diseases by meshing medical imaging, machine learning and AI.
Currently, only about 20% of all cancer patients will actually benefit from immunotherapy, a treatment that differs from chemotherapy in that it uses drugs to help your immune system fight cancer, while chemotherapy uses drugs to directly kill cancer cells, according to the National Cancer Institute.
Madabhushi said the recent work by his lab would help oncologists know which patients would actually benefit from the therapy, and who would not.
“Even though immunotherapy has changed the entire ecosystem of cancer, it also remains extremely expensive—about $200,000 per patient, per year,” Madabhushi said. “That’s part of the financial toxicity that comes along with cancer and results in about 42% of all new diagnosed cancer patients losing their life savings within a year of diagnosis.”
Having a tool based on the research being done now by his lab would go a long way toward “doing a better job of matching up which patients will respond to immunotherapy instead of throwing $800,000 down the drain,” he added, referencing the four patients out of five who will not benefit, multiplied by annual estimated cost.
New research published
The new research, led by co-authors Mohammadhadi Khorrami and Prateek Prasanna, along with Madabhushi and 10 other collaborators from six different institutions (see list, below) was published this month in the journal Cancer Immunology Research.
Khorrami, a graduate student working at the CCIPD, said one of the more significant advances in the research was the ability of the computer program to note the changes in texture, volume and shape of a given lesion, not just its size.
“This is important because when a doctor decides based on CT images alone whether a patient has responded to therapy, it is often based on the size of the lesion,” Khorrami said. “We have found that textural change is a better predictor of whether the therapy is working.
“Sometimes, for example, the nodule may appear larger after therapy because of another reason, say a broken vessel inside the tumor—but the therapy is actually working. Now, we have a way of knowing that.”
Prasanna, a postdoctoral research associate in Madabhushi’s lab, said the study also showed that the results were consistent across scans of patients treated at two different sites and with three different types of immunotherapy agents.
“This is a demonstration of the fundamental value of the program, that our machine-learning model could predict response in patients treated with different immune checkpoint inhibitors,” he said. “We are dealing with a fundamental biological principal.”
Prasanna said the initial study used CT scans from 50 patients to train the computer and create a mathematical algorithm to identify the changes in the lesion. He said the next step will be to test the program on cases obtained from other sites and across different immunotherapy agents. This research recently won an ASCO 2019 Conquer Cancer Foundation Merit Award.
Additionally, Madabhushi said, researchers were able show that the patterns on the CT scans which were most associated with a positive response to treatment and with overall patient survival were also later found to be closely associated with the arrangement of immune cells on the original diagnostic biopsies of those patients.
This suggests that those CT scans actually appear to capturing the immune response elicited by the tumors against the invasion of the cancer—and that the ones with the strongest immune response were showing the most significant textural change and most importantly, would best respond to the immunotherapy, he said.
Madabhushi established the CCIPD at Case Western Reserve in 2012. The lab now includes nearly 60 researchers.
Some of the lab’s most recent work, in collaboration with New York University and Yale University, has used AI to predict which lung cancer patients would benefit from adjuvant chemotherapy based on tissue-slide images. That advancement was named by Prevention Magazine as one of the top 10 medical breakthroughs of 2018.
Learn more: Using Artificial Intelligence to determine whether immunotherapy is working
The Latest Google Headlines on:
Immunotherapy
[google_news title=”” keyword=”immunotherapy ” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Immunotherapy
- Ketone supplement boosts efficacy of prostate cancer immunotherapyon April 26, 2024 at 7:51 pm
and Mary Jo Boler Collegiate Associate Professor in the Department of Biological Sciences, and collaborators tackled a problem oncologists have battled: Prostate cancer is resistant to a type of ...
- Can cancer vaccine with immunotherapy shrink liver tumor?on April 26, 2024 at 7:30 pm
According to a study published in the journal Nature Medicine, people with Hepatocellular Carcinoma treated with immunotherapy and a personalized anti-tumor vaccine were twice as likely to experience ...
- Immunotherapy and hay feveron April 26, 2024 at 2:09 am
Hope is at hand, however, in the form of immunotherapy. The most acute hay fever sufferers are sometimes referred for the treatment, and now new research "highlighting its effectiveness" may lead to ...
- Side effects of immunotherapy for cancer treatmenton April 25, 2024 at 5:31 pm
Trenton Stewart of Davenport is charged with forging checks stolen during break-in. Moline City Council endorsed the $6.8 million redevelopment proposal to convert the old JCPenny building to ...
- Vitamin D may balance gut microbiome to give cancer immunotherapy a booston April 25, 2024 at 12:30 pm
A new study in mice found that dietary vitamin D plays a role in balancing the gut microbiome and improving the way cancer immunotherapy works to fight tumors.
- Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Canceron April 24, 2024 at 2:43 am
FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after UCLA-led research shows improved outcomes for patients.
- FDA approves immunotherapy drug combo for non-muscle invasive bladder canceron April 23, 2024 at 10:44 am
The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be used in combination with the immunotherapy ...
- AI could predict whether cancer treatments will work, experts say: ‘Exciting time in medicine'on April 23, 2024 at 3:00 am
A chemotherapy alternative called immunotherapy is showing promise in treating cancer — and a new artificial intelligence tool could help ensure that patients have the best possible experience.
- Scientists making progress in less toxic cancer treatment called immunotherapyon April 22, 2024 at 3:04 pm
Scientists are making progress in using less toxic immunotherapy instead of traditional chemotherapy to fight cancer.
- Improving cancer immunotherapy by prolonging T-cell survivalon April 22, 2024 at 1:20 pm
In the past decade, immunotherapy has emerged as the fourth pillar of cancer treatment, joining surgery, radiotherapy and chemotherapy. It is an approved treatment for 15 cancers, including melanoma ...
The Latest Google Headlines on:
Artificial intelligence diagnostics
[google_news title=”” keyword=”artificial intelligence diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Artificial intelligence diagnostics
- Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insighton April 25, 2024 at 10:05 pm
Quest Diagnostics Inc demonstrates robust financial performance with significant revenue from its DIS business. Recent acquisitions and the Invigorate program highlight the company's strategic growth ...
- The Impact of Artificial Intelligence on Job Market Trendson April 25, 2024 at 3:49 am
Are robots taking over our jobs? Will artificial intelligence make human labor obsolete? These questions have been wandering over the job market for years, sparking debates and fears about the future ...
- Randomised controlled trials evaluating artificial intelligence in clinical practice: a scoping reviewon April 24, 2024 at 5:39 pm
This scoping review of randomised controlled trials on artificial intelligence (AI) in clinical practice reveals an expanding interest in AI across clinical specialties and locations. The USA and ...
- Artificial intelligence can evaluate cardiovascular risk during CT scanon April 24, 2024 at 7:25 am
A recent study designed and implemented by investigators at Cedars-Sinai found that artificial intelligence (AI) can accurately evaluate cardiovascular risk during a routine chest computed tomography ...
- Role of AI, Robotics will increase in diagnostics and treatment: President Murmu at AIIMS Rishikeshon April 24, 2024 at 2:19 am
The President said that using the latest technology in the interest of society should be the priority of institutions like AIIMS Rishikesh. She expressed happiness over AIIMS Rishikesh striving to ...
- Artificial Intelligence Helps Detect Dry Eye Diseaseon April 23, 2024 at 11:07 am
AI's ongoing learning process acts as a catalyst, driving research forward by contributing to predictive models for dry eye disease.
- Artificial intelligence to be used for the detection of common eye diseaseon April 23, 2024 at 6:14 am
In this study, researchers aim to use artificial intelligence (AI) to aid in early screening ... “However, there are still challenges for engineers to select the diagnostic standards and combinations ...
- Vayiz Unveils PTLC - Mark 1: Revolutionizing Medical Diagnostics with Pioneering AI Technologyon April 22, 2024 at 6:48 am
Vayiz, an exciting new startup in innovative AI-driven medical imaging solutions, today announced the launch of its groundbreaking product, PTLC - Mark 1. This advanced medical diagnosis software ...
- The Role Of Artificial Intelligence In Optimising Electric Vehicle Performanceon April 19, 2024 at 6:30 am
Through its capacity to process massive datasets and discern patterns in real-time, AI empowers EV technology with informed decision-making capabilities.
- AI rivals humans in ophthalmology exams: GPT-4's impressive diagnostic skills showcasedon April 18, 2024 at 10:59 pm
Researchers compared the clinical knowledge of large language models (LLMs) like GPT-4 to human experts in ophthalmology, revealing that GPT-4 can match or surpass trainee doctors in diagnostic ...